(Q52075649)

21 April 2018

title

Intent-to-treat analysis and preventive vaccine efficacy. (English)

1 reference

21 April 2018

2

Lachenbruch PA

0 references

author name string

Horne AD

series ordinal

1

1 reference

21 April 2018

Goldenthal KL

series ordinal

3

1 reference

21 April 2018

language of work or name

English

0 references

publication date

1 September 2000

1 reference

21 April 2018

published in

Vaccine

1 reference

21 April 2018

volume

19

1 reference

21 April 2018

issue

2-3

1 reference

21 April 2018

page(s)

319-326

1 reference

21 April 2018

Analysis of clinical trials by treatment actually received: is it really an option?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Intention to treat--who should use ITT?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

The randomized clinical trial: bias in analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Controversy in Counting and Attributing Events in Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

A review of the design of vaccine efficacy trials and a proposal for the design of the VA Cooperative Study of Active Immunotherapy of HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Active Immunization of Patients with HIV Infection: A Study of the Effect of VaxSyn, a Recombinant HIV Envelope Subunit Vaccine, on Progression of Immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

What are pragmatic trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Drug compliance in therapeutic trials: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

A placebo-controlled trial of a pertussis-toxoid vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Francis field trial of inactivated poliomyelitis vaccine: background and lessons for today

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Protective activity of Vi capsular polysaccharide vaccine against typhoid fever

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Adjusting for non-compliance and contamination in randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

Trials to assess equivalence: the importance of rigorous methods

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900152-3

7 January 2021

10.1016/S0264-410X(00)00152-3

Identifiers

DOI

1 reference

21 April 2018

PubMed ID

10930687

1 reference

21 April 2018